PRIMARY STUDY
Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant
Key Findings: The authors describe a growing number of trials focusing on cannabimimetic ligands, that can act as CBR agonists or antagonist, or ECS enzyme inhibitors including terpenes such as β-caryophyllene, limonene, and terpineol for example, which may play a significant role in the modulation of different pathological conditions.
Type of Study: Meta-analysis
Study Result: Positive
Research Location(s): Brazil, Italy, United States
Year of Pub: 2020
Cannabinoids Studied:
Phytocannabinoid Source: Not Applicable
Terpenes Studied: ß-Caryophyllene, Limonene, Terpineol
Receptors Studied: CB2
Citation: Gonçalves ECD, et al. Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant. Molecules. 2020; 25:(unknown pages). doi: 10.3390/molecules25071567
Authors: Gonçalves ECD, Baldasso GM, Bicca MA, Paes RS, Capasso R, Dutra RC
